FGFR3 and renal pelvis/ureter urothelial carcinoma: Moreover, mutations in chromatin remodeling genes (KMT2D/KDM6A) and tumor suppressor genes (TP53) are observed in 35–56% and 18–26% of UTUC cases, respectively, with FGFR3 mutations correlating with a better prognosis.